Keyphrases
HIV-associated Dementia
100%
Multicenter AIDS Cohort Study
100%
Temporal Trends
100%
Neurological Diseases
100%
Sensory Neuropathy
83%
Immunosuppression
50%
Incidence Rate
33%
Toxoplasmosis
33%
Antiretroviral Agents
33%
Antimicrobial Prophylaxis
33%
Cryptococcal Meningitis
33%
AIDS/HIV
16%
Antiretroviral Therapy
16%
CD4+
16%
Antimicrobial
16%
Primary Central Nervous System Lymphoma (PCNSL)
16%
Progressive multifocal Leukoencephalopathy
16%
Stavudine
16%
Zalcitabine
16%
Didanosine
16%
HIV-related
16%
Linear Trend
16%
Poisson Model
16%
Neurologic Disorders
16%
Cell Count
16%
Trends over Time
16%
Neurologic Conditions
16%
Medicine and Dentistry
Cohort Analysis
100%
Neurologic Disease
100%
Human Immunodeficiency Virus
100%
HIV-associated Neurocognitive Disorder
100%
Sensory Neuropathy
83%
Immunosuppressive Treatment
50%
Antiinfective Agent
50%
Toxoplasmosis
33%
Antiretrovirus Agent
33%
Cryptococcal Meningitis
33%
Drug Therapy
16%
Progressive Multifocal Leukoencephalopathy
16%
Stavudine
16%
Didanosine
16%
Zalcitabine
16%
Cell Count
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Cohort Study
100%
Neurologic Disease
100%
HIV Associated Dementia
100%
Sensory Neuropathy
83%
Antiinfective Agent
50%
Antiretrovirus Agent
33%
Toxoplasmosis
33%
Cryptococcal Meningitis
33%
Pharmacotherapy
16%
Stavudine
16%
Zalcitabine
16%
Didanosine
16%
Progressive Multifocal Leukoencephalopathy
16%
Neuroscience
Human Immunodeficiency Virus
100%
HIV Associated Dementia
100%
Nervous System Disorder
100%
Peripheral Neuropathy
83%
Immunosuppression
50%
Antimicrobials
50%
Meningitis
33%
CD4
16%
Progressive Multifocal Leukoencephalopathy
16%
Didanosine
16%
Stavudine
16%
Antiretroviral Drugs
16%
Zalcitabine
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Immunosuppression
33%
Toxoplasmosis
22%
Meningitis
22%
CD4 Lymphocyte Count
11%